317 related articles for article (PubMed ID: 11788882)
1. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
Grabarek J; Dragan M; Lee BW; Johnson GL; Darzynkiewicz Z
Int J Oncol; 2002 Feb; 20(2):225-33. PubMed ID: 11788882
[TBL] [Abstract][Full Text] [Related]
2. Sequential activation of caspases and serine proteases (serpases) during apoptosis.
Grabarek J; Du L; Johnson GL; Lee BW; Phelps DJ; Darzynkiewicz Z
Cell Cycle; 2002; 1(2):124-31. PubMed ID: 12429921
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspases and serine proteases during apoptosis induced by onconase (Ranpirnase).
Grabarek J; Ardelt B; Du L; Darzynkiewicz Z
Exp Cell Res; 2002 Aug; 278(1):61-71. PubMed ID: 12126958
[TBL] [Abstract][Full Text] [Related]
4. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases.
Shimizu T; Pommier Y
Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
[TBL] [Abstract][Full Text] [Related]
6. Pro- and anti-apoptotic effects of an inhibitor of chymotrypsin-like serine proteases.
King MA; Halicka HD; Darzynkiewicz Z
Cell Cycle; 2004 Dec; 3(12):1566-71. PubMed ID: 15539954
[TBL] [Abstract][Full Text] [Related]
7. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation.
Bedner E; Smolewski P; Amstad P; Darzynkiewicz Z
Exp Cell Res; 2000 Aug; 259(1):308-13. PubMed ID: 10942603
[TBL] [Abstract][Full Text] [Related]
8. Involvement of TLCK-sensitive serine protease in colchicine-induced cell death of sympathetic neurons in culture.
Mitsui C; Sakai K; Ninomiya T; Koike T
J Neurosci Res; 2001 Nov; 66(4):601-11. PubMed ID: 11746380
[TBL] [Abstract][Full Text] [Related]
9. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
Hughes FM; Evans-Storms RB; Cidlowski JA
Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
[TBL] [Abstract][Full Text] [Related]
10. Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells.
Yoshida A; Takauji R; Inuzuka M; Ueda T; Nakamura T
Leukemia; 1996 May; 10(5):821-4. PubMed ID: 8656677
[TBL] [Abstract][Full Text] [Related]
11. In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors.
Grabarek J; Darzynkiewicz Z
Exp Hematol; 2002 Sep; 30(9):982-9. PubMed ID: 12225789
[TBL] [Abstract][Full Text] [Related]
12. Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease.
Murn J; Urleb U; Mlinaric-Rascan I
Genes Cells; 2004 Nov; 9(11):1103-11. PubMed ID: 15507121
[TBL] [Abstract][Full Text] [Related]
13. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.
Sané AT; Bertrand R
Cancer Res; 1998 Jul; 58(14):3066-72. PubMed ID: 9679972
[TBL] [Abstract][Full Text] [Related]
14. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents.
Lotem J; Sachs L
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12507-12. PubMed ID: 8901612
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
Schmitt E; Cimoli G; Steyaert A; Bertrand R
Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
[TBL] [Abstract][Full Text] [Related]
16. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Dec; 105(6):1501-6. PubMed ID: 18980241
[TBL] [Abstract][Full Text] [Related]
17. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation.
Sané AT; Schmitt E; Steyaert A; Meyer D; Bertrand R
Biochem Cell Biol; 1997; 75(4):359-68. PubMed ID: 9493958
[TBL] [Abstract][Full Text] [Related]
18. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity.
Wright SC; Schellenberger U; Wang H; Kinder DH; Talhouk JW; Larrick JW
J Exp Med; 1997 Oct; 186(7):1107-17. PubMed ID: 9314559
[TBL] [Abstract][Full Text] [Related]
19. Effect of serine protease inhibitors on posttraumatic brain injury and neuronal apoptosis.
Movsesyan VA; Yakovlev AG; Fan L; Faden AI
Exp Neurol; 2001 Feb; 167(2):366-75. PubMed ID: 11161625
[TBL] [Abstract][Full Text] [Related]
20. A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells.
Bestilny LJ; Riabowol KT
Exp Cell Res; 2000 Apr; 256(1):264-71. PubMed ID: 10739673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
